Table IV.
Plasma S100B levels according to the TT and AA/AT variants of the rs2269422 polymorphism of receptor for advanced glycation end products.
S100B (pg/ml) | ||
---|---|---|
Group | TT | AA/AT |
Control (n=90) | 95.52±28.98 | 129.43±21.34 |
CAD (n=70) | 201.24±32.68a | 286.69±63.91a |
P<0.05 vs. the control group. Values are expressed as the mean ± standard deviation. S100B, S100 calcium binding protein B; CAD, coronary artery disease.